Cargando…

Activity of regorafenib in advanced pretreated soft tissue sarcoma: Results of a single-center phase II study

BACKGROUND: Regorafenib, a multitargeted tyrosine kinase inhibitor, proved to be active in patients with soft tissue sarcomas (STS). METHODS: We conducted an open-label, non-randomized, single-center phase II study in advanced pretreated STS patients. Patients received regorafenib 160 mg daily on da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marrari, Andrea, Bertuzzi, Alexia, Bozzarelli, Silvia, Gennaro, Nicolò, Giordano, Laura, Quagliuolo, Vittorio, De Sanctis, Rita, Sala, Simona, Balzarini, Luca, Santoro, Armando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328961/ https://www.ncbi.nlm.nih.gov/pubmed/32590747 http://dx.doi.org/10.1097/MD.0000000000020719

Ejemplares similares

Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma
por: De Sanctis, Rita, et al.
Publicado: (2015)

Low Incidence of SARS-CoV-2 in Patients with Solid Tumours on Active Treatment: An Observational Study at a Tertiary Cancer Centre in Lombardy, Italy
por: Bertuzzi, Alexia Francesca, et al.
Publicado: (2020)

The radiologist empowerment through virtual multidisciplinary tumor boards: The commitment of oncologic care during COVID-19 pandemic
por: Gennaro, Nicolò, et al.
Publicado: (2021)

Impact of active cancer on COVID-19 survival: a matched-analysis on 557 consecutive patients at an Academic Hospital in Lombardy, Italy
por: Bertuzzi, Alexia F., et al.
Publicado: (2021)

The blurred line between the art and science of medicine()
por: Bertuzzi, Alexia Francesca, et al.
Publicado: (2020)

Prognostic value of pretreatment anemia in patients with soft tissue sarcoma: A meta-analysis
por: Shi, Landa, et al.
Publicado: (2021)

Multidisciplinary management of adolescents and young adults (AYA) sarcoma: A successful effort of an adult high‐volume cancer center
por: Bertuzzi, Alexia Francesca, et al.
Publicado: (2023)

Case Report: Should Regorafenib be prescribed as a continuous schedule in gastrointestinal stromal tumors? Three case reports on Regorafenib personalized schedule
por: Grimaudo, Maria Susanna, et al.
Publicado: (2023)

The current management of alveolar soft part sarcomas
por: Chang, Xiaojing, et al.
Publicado: (2021)

A nomogram to predict metastasis of soft tissue sarcoma of the extremities
por: Li, Ruo-He, et al.
Publicado: (2020)

Nivolumab plus regorafenib in patients with small bowel adenocarcinoma: A case report
por: Zhang, Gairong, et al.
Publicado: (2021)

Alveolar soft part sarcoma of the right calf: A case report
por: Wang, Bin, et al.
Publicado: (2020)

Multi-Step Combined Upfront Surgery for Locally Advanced Paravertebral Sarcoma: A Case Report
por: Cariboni, Umberto, et al.
Publicado: (2021)

VIP (etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma
por: Moon, Ji Young, et al.
Publicado: (2017)

Lingual alveolar soft part sarcoma responsive to pazopanib: A case report
por: Yoshihiro, Tomoyasu, et al.
Publicado: (2017)

Never too old to fight breast cancer: A case report
por: Zuradelli, Monica, et al.
Publicado: (2018)

Rare cardiac metastasis of soft tissue sarcoma: A case report and literature review
por: Xiao, Jun, et al.
Publicado: (2018)

PLCG2 as a potential indicator of tumor microenvironment remodeling in soft tissue sarcoma
por: Li, Zhengtian, et al.
Publicado: (2021)

DNA methylation patterns–based subtype distinction and identification of soft tissue sarcoma prognosis
por: Li, Kai, et al.
Publicado: (2021)

Unexpected side effect in mCRC: A care-compliant case report of regorafenib-induced hyperammonemic encephalopathy
por: Quirino, Michela, et al.
Publicado: (2017)

Regorafenib-induced retinal and gastrointestinal hemorrhage in a metastatic colorectal cancer patient with liver dysfunction: A case report
por: Tsuchihashi, Kenji, et al.
Publicado: (2017)

Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients
por: Wang, Bing, et al.
Publicado: (2016)

Wide resection of soft tissue sarcomas after unplanned primary procedures: A long-term follow-up study
por: Kang, Jian, et al.
Publicado: (2020)

Therapeutic effects of regorafenib after sorafenib monotherapy with advanced hepatocellular carcinoma including Child–Pugh classification B: A retrospective observational study
por: Komiyama, Satoshi, et al.
Publicado: (2020)

A Phase II Study of Gemcitabine, Vincristine, and Cisplatin (Gvp) As Second-Line Treatment for Patients with Advanced Soft Tissue Sarcoma
por: Luo, Zhiguo, et al.
Publicado: (2015)

The role of stereotactic body radiation therapy in oligometastatic colorectal cancer: Clinical case report of a long-responder patient treated with regorafenib beyond progression
por: Roberto, Michela, et al.
Publicado: (2017)

Efficacy analysis of the aprepitant-combined antiemetic prophylaxis for non-round cell soft-tissue sarcoma patients received adriamycin and ifosfamide therapy
por: Kusaba, Hitoshi, et al.
Publicado: (2016)

Prognostic value of (18)F-FDG PET-CT-based functional parameters in patients with soft tissue sarcoma: A meta-analysis
por: Chen, Linyan, et al.
Publicado: (2017)

Comparative efficacy and safety for second-line treatment with ramucirumab, regorafenib, and cabozantinib in patients with advanced hepatocellular carcinoma progressed on sorafenib treatment: A network meta-analysis
por: Chen, Jianxin, et al.
Publicado: (2021)

Novel-fosfamide monotherapy or in combination with doxorubicin versus doxorubicin alone in patients with advanced soft tissue sarcoma: A pooled analysis of randomized clinical trials
por: Liu, Xin-Xiu, et al.
Publicado: (2023)

Unsupervised versus Supervised Identification of Prognostic Factors in Patients with Localized Retroperitoneal Sarcoma: A Data Clustering and Mahalanobis Distance Approach
por: De Sanctis, Rita, et al.
Publicado: (2018)

Prognostic value of pretreatment (18)F-FDG PET-CT for nasopharyngeal carcinoma patients
por: Huang, Yecai, et al.
Publicado: (2017)

Treatment of limb synovial sarcoma with metastasis at presentation
por: Guo, Pan, et al.
Publicado: (2020)

Nomograms predicting local and distant recurrence and disease-specific mortality for R0/R1 soft tissue sarcomas of the extremities
por: De Sanctis, Rita, et al.
Publicado: (2022)

Efficacy of Oral Etoposide in Pretreated Metastatic Breast Cancer: A Multicenter Phase 2 Study
por: Yuan, Peng, et al.
Publicado: (2015)

Identifying pretreatment baseline factors predictive of distant metastasis in patients with nasopharyngeal carcinoma after radiotherapy
por: Wang, Yu, et al.
Publicado: (2017)

Acute lymphoblastic leukemia arising after treatment of Ewing sarcoma was misdiagnosed as bone marrow metastasis of Ewing sarcoma: A case report
por: Li, Xiaohong, et al.
Publicado: (2018)

Primary renal synovial sarcoma: A case report
por: Zhang, Bei, et al.
Publicado: (2020)

Impact of age for overall survival in head and neck sarcoma
por: Suzuki, Hidenori, et al.
Publicado: (2023)

Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis
por: Su, Li, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4b00d3nl8clk8fqcartpqi82e4